Mission Statement
" To provide accurate, reliable, and sensitive measurement instrumentation and data. To acknowledge our limits, act with integrity, and strive together with our peers and customers to advance scientific discovery. "
Established in 1995 by founders Steve Lackie and Tom Glass, Sapidyne Instruments has emerged as a global leader in biomolecular interaction analysis. The pioneering deployment of KinExA technology at prestigious institutions, including Xavier University, the United States Army, and the Environmental Protection Agency, showcased its transformative capabilities. Through decades of strategic collaborations with world-renowned researchers, Sapidyne's KinExA platform has become an essential tool for characterizing binding interactions, earning the trust of leading pharmaceutical companies, academic institutions, and research organizations worldwide.
Based in Boise, Idaho, Sapidyne Instruments operates a state-of-the-art contract research laboratory and manufactures all KinExA instruments at our Idaho headquarters, adhering to the highest standards of quality and precision. To serve our European clientele, we maintain a dedicated office in Hannover, Germany, providing comprehensive support. Our global reach is further enhanced through authorized distributors in Japan, Singapore, South Korea, and China. As Sapidyne continues to expand, our dedication to exceptional customer support and fostering collaborative innovation remains steadfast.
Based in Boise, Idaho, Sapidyne Instruments operates a state-of-the-art contract research laboratory and manufactures all KinExA instruments at our Idaho headquarters, adhering to the highest standards of quality and precision. To serve our European clientele, we maintain a dedicated office in Hannover, Germany, providing comprehensive support. Our global reach is further enhanced through authorized distributors in Japan, Singapore, South Korea, and China. As Sapidyne continues to expand, our dedication to exceptional customer support and fostering collaborative innovation remains steadfast.
